Uncategorized
Ocular Therapeutix reports $18.7 million loss in second quarter
Ocular Therapeutix reported a net loss of $18.7 million, or $0.64 per share, in the second quarter of 2017 compared with a net loss of $11.4 million, or $0.46 per share, in 2016’s second quarter.Product sales of ReSure sealant generated $0.4 million in revenue, according to a press release.